Mentice AB (publ) (STO:MNTC)

Sweden flag Sweden · Delayed Price · Currency is SEK
13.50
-1.50 (-10.00%)
Jun 27, 2025, 5:22 PM CET
-52.30%
Market Cap 383.53M
Revenue (ttm) 300.84M
Net Income (ttm) -21.29M
Shares Out 25.57M
EPS (ttm) -0.83
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 18,527
Average Volume 7,263
Open 14.90
Previous Close 15.00
Day's Range 13.30 - 14.90
52-Week Range 13.35 - 40.00
Beta 0.69
RSI 37.58
Earnings Date Jul 24, 2025

About Mentice AB

Mentice AB (publ) develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; patient simulator accessories and extensions for endovascular therapies; and Angi... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 131
Stock Exchange Nasdaq Stockholm
Ticker Symbol MNTC
Full Company Profile

Financial Performance

In 2024, Mentice AB's revenue was 291.81 million, an increase of 6.07% compared to the previous year's 275.12 million. Losses were -18.42 million, 553.9% more than in 2023.

Financial Statements

News

There is no news available yet.